Detalhe da pesquisa
1.
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancer.
bioRxiv;
2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790484
2.
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance.
Nat Cancer;
4(6): 872-892, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142692
3.
Context-Dependent Requirement of Euchromatic Histone Methyltransferase Activity during Reprogramming to Pluripotency.
Stem Cell Reports;
15(6): 1233-1245, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976761